Additional FKBPs have been put forward as potential drug targets in steroid hormone-associated cancer and psychotic disorders (FKBP4, 5, 8), and Alzheimer’s disease (FKBP1A, 4, 5) [15,72,86]. This evidence concerns the gene FKBP1A and psychotic disorder.